학술논문

Subcutaneous Marzeptacog Alfa (Activated) for On-Demand Treatment of Bleeding Events in Subjects With Hemophilia A or B With Inhibitors
Document Type
Article
Source
In: Clinical Pharmacology and Therapeutics. (Clinical Pharmacology and Therapeutics, March 2024, 115(3):498-505)
Subject
Language
English
ISSN
15326535
00099236